# Efficacy and Safety With Ziprasidone in First-episode Psychosis

> **NCT01157559** · PHASE4 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 27 (actual)

## Conditions studied

- First Episode Psychosis

## Interventions

- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT01157559
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2008-06
- **Final completion:** 2010-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157559, "Efficacy and Safety With Ziprasidone in First-episode Psychosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01157559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*